1,5,8,12-TETRAKIS(4,6-BIS(N-BUTYL-N-1,2,2,6,6-PENTAMETHYL-4-PIPERIDYLAMINO)-1,3,5-TRIAZIN-2-YL)-1,12-DIMETHYL-1,5,8,12-TETRAAZADODECANE
UNII 7O59CDL7VL
Substance Identification & Data
This profile provides standardized clinical and technical data for 1,5,8,12-tetrakis(4,6-bis(n-butyl-n-1,2,2,6,6-pentamethyl-4-piperidylamino)-1,3,5-triazin-2-yl)-1,12-dimethyl-1,5,8,12-tetraazadodecane, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7O59CDL7VL.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 115810-23-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C134H254N32 BPHATVWDXJIZMT-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1,5,8,12-tetrakis(4,6-bis(n-butyl-n-1,2,2,6,6-pentamethyl-4-piperidylamino)-1,3,5-triazin-2-yl)-1,12-dimethyl-1,5,8,12-tetraazadodecane. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.